Merging Pharmacometabolomics with Pharmacogenomics using “1000 Genomes” SNP Imputation: Selective Serotonin Reuptake Inhibitor Response Pharmacogenomics

OBJECTIVE: We set out to test the hypothesis that pharmacometabolomic data could be efficiently merged with pharmacogenomic data by SNP imputation of metabolomic-derived pathway data on a “scaffolding” of genome-wide association (GWA) SNP data to broaden and accelerate “pharmacometabolomics-informed...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Abo, Ryan, Hebbring, Scott, Ji, Yuan, Zhu, Hongjie, Zeng, Zhao-Bang, Batzler, Anthony, Jenkins, Gregory D., Biernacka, Joanna, Snyder, Karen, Drews, Maureen, Fiehn, Oliver, Fridley, Brooke, Schaid, Daniel, Kamatani, Naoyuki, Nakamura, Yusuke, Kubo, Michiaki, Mushiroda, Taisei, Kaddurah-Daouk, Rima, Mrazek, David A., Weinshilboum, Richard M.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2012
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3303952/
https://ncbi.nlm.nih.gov/pubmed/22322242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32835001c9
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة